Chemical Structure (Seladelpar 01)
Livdelzi Capsule
Product Images NDC 61958-3301
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Livdelzi (NDC 61958-3301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gilead Sciences, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Seladelpar 02)
This appears to be a chart or graph with data related to ALP (Alkaline phosphatase) levels over a 12-month period for a placebo group (N=65) and a group taking LIVDELZI 10 mg (N=128). The data seems to show measurements at different time points ranging from 0 to 8 months, with values indicated on the y-axis from 0 to 350.*
Principal Display Panel (10 mg Capsule Bottle Label)
The text has provided information about a medication named seladelpar, in capsule form. Each capsule contains less than 10mg of seladelpar, which is equivalent to 14.1 mg of seladelpar lysine. The dosage information is not fully visible in the text, but it advises seeing Prescribin instructions. It also mentions storage instructions, such as keeping the capsules between 68°F - 77°F and avoiding temperature excursions beyond 59°F - 86°F. The text includes a caution to keep the medication out of reach of children. This product is intended for oral use only. The medication is distributed by Gilead Sciences, Inc. located in Foster City, CA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
